Choose a peptide or peptide-adjacent item to review its context and compare classified clinical offers. Research-only and consumer products remain separately labeled and never enter clinical price rankings.
Complete catalog
Browse the complete tracked catalog
Catalog order is not a ranking.
105 tracked items shown
FDA-approved product exists59 clinical providers
Semaglutide
Also known as Ozempic, Wegovy, Rybelsus
Weight & metabolic
FDA-approved semaglutide products exist. Compounded versions are not FDA-approved generic equivalents, and availability depends on the specific provider, prescription, product, and state.
FDA-approved tirzepatide products exist. Compounded versions are not FDA-approved generic equivalents, and availability depends on the specific provider, prescription, product, and state.
Retatrutide remains investigational and is not an FDA-approved drug. Recess Rx and LeadWest advertise access, but FDA says retatrutide cannot be used in compounding under federal law; advertising is not proof of lawful availability or dispensing.
Cagrilintide is investigational and is not an FDA-approved drug. A provider listing is shown as seller-claimed evidence, not approval or a legal conclusion.
FDA-approved oxytocin injection has obstetric uses. Compounded nasal, troche, wellness, or sexual-health listings are different unapproved products and require route-specific review.
There is no FDA-approved GHK-Cu prescription drug. Non-injectable and injectable formulations have materially different regulatory context; observed creams are labeled separately here.
There is no FDA-approved Melanotan II human drug. FDA identifies quality concerns and serious adverse-event reports; seller listings are not approval or safety evidence.
No FDA-approved Epitalon product exists. A July 2026 advisory vote was nonbinding and did not itself approve a product or change federal compounding rules.
No FDA-approved MOTS-c product exists. A July 2026 advisory vote was nonbinding and did not itself approve a product or change federal compounding rules.
Egrifta is FDA-approved for a specific HIV-associated lipodystrophy indication and is not indicated for general weight-loss management. Compounded combinations are not the approved product.
There is no FDA-approved CJC-1295 product. FDA reports limited clinical data and serious adverse events; seller listings require independent verification.
There is no FDA-approved ipamorelin product. FDA's interim compounding-policy treatment is not approval, and observed seller listings require verification.
No FDA-approved BPC-157 human drug exists. A July 2026 advisory vote was nonbinding and did not itself approve a product or change federal compounding rules.
No FDA-approved TB-500 product exists. A July 2026 advisory vote was nonbinding; TB-500 is a fragment and should not be conflated with full-length thymosin beta-4.
There is no FDA-approved U.S. thymosin alpha-1 product. FDA says safety information is inadequate, and seller listings require independent verification.
No FDA-approved Semax product exists. A July 2026 advisory vote was nonbinding and did not itself approve a product or change federal compounding rules.
There is no FDA-approved Selank human drug. FDA says important human safety information is lacking, and seller listings require independent verification.
Regulatory context under review0 clinical providers
Acetyl Dipeptide-1 Cetyl Ester
Also known as Calmosensine
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Acetyl Hexapeptide-30
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Acetyl Hexapeptide-8
Also known as Argireline
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review2 clinical providers
Acetyl Octapeptide-3
Also known as SNAP-8
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Acetyl sh-Heptapeptide-1
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Acetyl Tetrapeptide-5
Also known as Eyeseryl
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
AHK-Cu
Also known as Copper tripeptide AHK-Cu
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Biotinoyl Tripeptide-1
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Bronchogen
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Calcitonin Salmon
Also known as Salmon calcitonin
Recovery & injury
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Cardiogen
Longevity
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Cartalax
Recovery & injury
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
CB4211
Weight & metabolic
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review3 clinical providers
Cibinetide
Also known as ARA-290
Recovery & injuryImmune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review3 clinical providers
Cyclosporine
Also known as Ciclosporin
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review6 clinical providers
Dihexa
Cognition, mood & sleep
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Dipeptide Diaminobutyroyl Benzylamide Diacetate
Also known as Syn-Ake
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review11 clinical providers
DSIP
Also known as Delta sleep-inducing peptide
Cognition, mood & sleep
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review3 clinical providers
Dulaglutide
Also known as Trulicity
Weight & metabolic
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
EGF
Also known as Epidermal growth factor
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review7 clinical providers
Elamipretide
Also known as SS-31, MTP-131
LongevityMuscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review2 clinical providers
Exenatide
Also known as Byetta, Bydureon
Weight & metabolic
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review2 clinical providers
FOXO4-DRI
Longevity
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
GHK
Also known as Glycyl-L-histidyl-L-lysine
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
GHRP-2
Also known as Pralmorelin
Muscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
GHRP-6
Muscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Glucagon
Weight & metabolic
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review41 clinical providers
Glutathione
Also known as GSH
Immune & inflammationSkin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review8 clinical providers
Gonadorelin
Also known as GnRH
Sexual health
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Hexapeptide-10
Also known as Serilesine
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Hexapeptide-11
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Hexarelin
Muscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
hGH Fragment 176-191
Also known as HGH Frag 176-191
Weight & metabolicMuscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review10 clinical providers
Human Chorionic Gonadotropin
Also known as hCG, Chorionic gonadotropin
Sexual health
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Humanin
Longevity
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
IGF-1
Also known as Insulin-like growth factor 1
Muscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
IGF-1 DES
Also known as DES(1-3) IGF-1
Muscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review8 clinical providers
IGF-1 LR3
Muscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Immune Peptide A2
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review6 clinical providers
Kisspeptin
Sexual health
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Kisspeptin-10
Sexual health
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review10 clinical providers
KPV
Also known as Lys-Pro-Val
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review2 clinical providers
Larazotide
Also known as Larazotide acetate, AT-1001
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review3 clinical providers
Linaclotide
Also known as Linzess
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review17 clinical providers
Liraglutide
Also known as Saxenda, Victoza
Weight & metabolic
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review7 clinical providers
LL-37
Also known as Cathelicidin LL-37
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Mazdutide
Also known as IBI362, LY3305677
Weight & metabolic
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Melanotan I
Also known as Afamelanotide analogue, MT-1
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Menotropins
Also known as Human menopausal gonadotropin, hMG
Sexual health
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Myristoyl Pentapeptide-16
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Myristoyl Tripeptide-31
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
N-Acetyl Selank
Cognition, mood & sleep
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
N-Acetyl Selank Amidate
Cognition, mood & sleep
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
N-Acetyl Semax
Cognition, mood & sleep
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
N-Acetyl Semax Amidate
Cognition, mood & sleep
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
OS-01 Peptide
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Palmitoyl Hexapeptide-19
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Palmitoyl Pentapeptide-4
Also known as Matrixyl
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Palmitoyl Tetrapeptide-7
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Palmitoyl Tripeptide-1
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Palmitoyl Tripeptide-5
Also known as Syn-Coll
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review4 clinical providers
PE-22-28
Cognition, mood & sleep
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
PEG-MGF
Also known as PEGylated mechano growth factor
Muscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review3 clinical providers
Pentadeca Arginate
Recovery & injury
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Pentapeptide-18
Also known as Leuphasyl
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review6 clinical providers
Pinealon
Cognition, mood & sleepLongevity
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
PNC-27
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
PTD-DBM
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Setmelanotide
Also known as Imcivree
Weight & metabolic
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
sh-Oligopeptide-10
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
sh-Oligopeptide-2
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
sh-Polypeptide-1
Also known as Recombinant human EGF
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
sh-Polypeptide-11
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
sh-Polypeptide-9
Skin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review2 clinical providers
Somatropin
Also known as Recombinant human growth hormone, rhGH
Muscle & performance
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Survodutide
Also known as BI 456906
Weight & metabolic
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Thymalin
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Thymogen
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review2 clinical providers
Thymosin Beta-4
Also known as Tbeta4, Tβ4
Recovery & injury
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Thymulin
Immune & inflammation
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review1 clinical provider
Vasoactive Intestinal Peptide
Also known as VIP, Aviptadil
Immune & inflammationCognition, mood & sleep
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Vesugen
Longevity
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Regulatory context under review0 clinical providers
Zinc Thymulin
Immune & inflammationSkin & hair
This entry records a provider-marketed peptide identity. Product class, route, formulation, approval status, lawful availability, and clinical appropriateness depend on the exact listing and are not established by catalog inclusion.
Peptide-adjacentRegulatory context under review54 clinical providers
NAD+
Also known as Nicotinamide adenine dinucleotide, NAD, NADH (reduced form)
LongevityCognition, mood & sleep
NAD+ is a nucleotide coenzyme, not a peptide. NADH is its reduced form. This peptide-adjacent entry is included because providers market these products alongside peptide and longevity services; each exact route, formulation, product class, and access pathway is shown separately.
The catalog includes peptides plus clearly labeled peptide-adjacent items such as NAD+ when providers market them alongside peptide services. It includes approved, compounded, unapproved, and investigational products where a listing has been documented. Provider-stated pricing and availability should be confirmed at the source.
Help expand the directory
Don’t see a peptide, provider, or supplier you’re interested in?